SpringWorks Therapeutics
James Smothers is a seasoned professional in the field of research biology, currently serving as Vice President at SpringWorks Therapeutics since May 2024. Prior experience includes a prominent role at GSK US from July 2010 to March 2024, where responsibilities encompassed leadership as Vice President of the Immuno-Oncology & Combinations Research Unit, along with various roles in oncology R&D. Earlier career highlights involve significant positions at Amgen, including Principal Scientist and Site Department Head, and foundational research experience at Immunex and the Fred Hutchinson Cancer Research Center. James Smothers holds a Ph.D. in Biology from the University of Rochester, an M.S. in Microbiology from Idaho State University, and a B.S. in Biology from the University of Missouri-Columbia.
This person is not in any teams
This person is not in any offices
SpringWorks Therapeutics
8 followers
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that ignites the power of promising science to unleash new possibilities for patients.